1HULLEY S, GRADY D, BUSH T, et al. Rmadonftzed trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women[J]. JAMA, 1998,280:605-613.
2MOSCA L,COLLINS P, HERRINGTON D M,et al. Hormone replaemamt therapy and cardiovascular disease : a statement for healthcare professicamls from the American Heart Association[J].Circulation, 2001,104: 499-503.
3JACQUE E, GARNET L, MARCIA L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women[J].JAMA, 2002,288(3) : 1.
4BURGER H, TEEDE H. The AHA guideline on hormone replacement therapy and cardiovascular diseases[J]. Maturitas,2001,40:1 - 3.
5BERESFORD S A, WEISS N S, VOIGT L F, et al. Risk ofendometrial cancer in relation to use of estrogen combined with cyclic progestin therapy in postmenopausal women [ J ]. Lancet,1997,349: 458 - 461.
6O' ODNNOR I F, SCHEMBEKAR M V, Shousha. Breast carcinoma developing in patients on hormone replacement therapy:a histological and immtmohistological study[J]. J Clin Pathol, 1998,51:935 - 938.
